Digital Genome Market
According to Intent Market Research, the Digital Genome Market is expected to grow from USD 28.4 billion in 2023 at a CAGR of 10.5% to touch USD 56.9 billion by 2030. The Digital Genome Market is dominated by key players such as Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences, Qiagen N.V., Agilent Technologies, Oxford Nanopore Technologies Ltd., PerkinElmer Inc., Bio-Rad Laboratories, Inc., Editas Medicine, Inc., CRISPR Therapeutics AG, Genomics plc, 10x Genomics, Inc., Synthego Corporation, Roche Holding AG, BGI Group